Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16
about
Closing the door on flaviviruses: Entry as a target for antiviral drug designStructure of human enterovirus 71 in complex with a capsid-binding inhibitorThe Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: A CryoEM Study of Picornavirus UncoatingA novel benzonitrile analogue inhibits rhinovirus replicationEfficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsVirion Structure of Israeli Acute Bee Paralysis Virus.Structure of deformed wing virus, a major honey bee pathogen.Pleconaril: a novel antipicornaviral drug.From laptop to benchtop to bedside: structure-based drug design on protein targets.Virion Structure of Iflavirus Slow Bee Paralysis Virus at 2.6-Angstrom Resolution.Virion Structure of Black Queen Cell Virus, a Common Honeybee Pathogen.How influenza virus is locked out of the cellStructure of Aichi virus 1 and its empty particle: clues towards kobuvirus genome release mechanism.Virus infection-induced bronchial asthma exacerbation.Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral CapsidsStructure-Based Pharmacophores for Virtual Screening.QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer.VP4 protein from human rhinovirus 14 is released by pressure and locked in the capsid by the antiviral compound WIN.
P2860
Q27487953-5B354CCC-BCF7-40BB-8427-F3966F3B07BCQ27676881-BF7811D7-4D45-4876-AC7B-E57ECA2D222BQ27677204-FF78DF85-6F20-470C-A21E-1A333B2C4BB1Q27690771-3F92DDAA-F221-4D23-A6F9-4729374FB7F9Q28178690-C65A6A27-9C15-4B03-994B-3E1B02505232Q30152760-C8168841-0562-4992-B9C8-8CC75846FCC3Q30843355-347D91FB-4665-42FE-BF5D-610937B26C3AQ31936167-7E7874E2-FA82-4259-ABE1-64D1AC0B24F7Q34153589-CA527966-A378-4108-A637-D1328528143DQ36046026-47D1282A-39F3-40E1-BED8-1CE8C2D41C19Q36246864-759D410E-72FB-4963-B8F8-345099507DFEQ37000020-129BA077-B462-42D8-A1B5-B573B001D2AAQ37415376-6F589E4C-2EFA-4F72-AC52-1B59D43A0649Q38042428-4308B5F5-C60C-4303-8236-523C8D3DCCABQ38763206-AFADE502-51EA-4624-B5A8-B6564A2FF9BEQ39750808-9156C06A-85E2-4F0F-8A91-A84E9E152CDAQ39768808-6CC4D448-431B-4ABA-AF04-1E020E4B892CQ40163296-106F9F66-6A4E-4BAB-B51C-7F99697AB21CQ40727573-779EF55D-D09C-48D4-9828-7EE911EB7984Q41353585-A01296DF-E979-4283-9EF4-0B18DBDF4BAE
P2860
Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Analysis of three structurally ...... mplex with human rhinovirus 16
@ast
Analysis of three structurally ...... mplex with human rhinovirus 16
@en
Analysis of three structurally ...... mplex with human rhinovirus 16
@nl
type
label
Analysis of three structurally ...... mplex with human rhinovirus 16
@ast
Analysis of three structurally ...... mplex with human rhinovirus 16
@en
Analysis of three structurally ...... mplex with human rhinovirus 16
@nl
prefLabel
Analysis of three structurally ...... mplex with human rhinovirus 16
@ast
Analysis of three structurally ...... mplex with human rhinovirus 16
@en
Analysis of three structurally ...... mplex with human rhinovirus 16
@nl
P2860
P3181
P356
P1476
Analysis of three structurally ...... mplex with human rhinovirus 16
@en
P2093
A T Hadfield
P2860
P304
P3181
P356
10.1073/PNAS.96.26.14730
P407
P577
1999-12-21T00:00:00Z